A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development
Lydia Beck(German Cancer Research Center), Cornelis M. van Tilburg(German Cancer Research Center), Claudia Rössig(Klinik und Poliklinik für Kinder- und Jugendmedizin), Till Milde(German Cancer Research Center), Simone Hettmer(Martin Luther University Halle-Wittenberg), Michael C. Frühwald(University Hospital Augsburg), Lenka A. Taylor(Heidelberg University), Matthias Fischer(Goethe University Frankfurt), Dirk Reinhardt(Society of Paediatric Oncology and Haematology), Ruth Witt(German Cancer Research Center), Claudia A. Riedel(Universidad Andrés Bello), Olaf Witt(German Cancer Research Center), Martina Nesper‐Brock(German Cancer Research Center)
Cited by 30
Related Papers
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383